THC Therapeutics, Inc. filed its 10-K on Nov 25, 2022 for the period ending Jul 31, 2022. In this report its auditor, Gries & Associates LLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0033 USD | +3.12% | +3.12% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 133K | |
-3.47% | 109B | |
-9.49% | 9.14B | |
+12.59% | 4.44B | |
+0.51% | 3.97B | |
+29.14% | 2.84B | |
+63.91% | 2.23B | |
-9.64% | 1.28B | |
+100.36% | 596M | |
+41.58% | 548M |
- Stock Market
- Equities
- THCT Stock
- News THC Therapeutics, Inc.
- THC Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt